Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NKTR-255 × Thoracic × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3 Thoracic 1 Plasma cell 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 155 Carboplatin 146 Cisplatin 129 Pemetrexed 103 Paclitaxel 89 Nivolumab 71 Radiotherapy 68 Docetaxel 61 Erlotinib Hydrochloride 58 Gemcitabine 57 Etoposide 44 osimertinib 43 Bevacizumab 43 Cyclophosphamide 42 durvalumab 41 atezolizumab 35 Cetuximab 33 130-nm albumin-bound paclitaxel 26 Radiosurgery 25 Ipilimumab 23 fludarabine 22 Irinotecan 21 Taxes 20 Radiation 20 Oxaliplatin 20 Magnetic Resonance Spectroscopy 20 Fluorouracil 20 Gefitinib 19 Everolimus 19 Topotecan 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05676749 2026-01-05

C-TIL051 in Non-Small Cell Lung Cancer

AbelZeta Inc.

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡